Is a complete MBX research report available?

No complete published report is available for MBX Biosciences, Inc. (MBX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

MBX Biosciences, Inc. (MBX)

NASDAQ: MBX · USD

$54.1

+1.11 (+2.1%)· Recorded snapshot

Market cap	2.6B
Net income (ttm)	-104.3M
EPS (ttm)	-$2.41
Shares out	48.2M
Volume	224,725
Beta	0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -104.3M
EPS (ttm): -$2.41
Market cap: 2.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001776111
Company name	MBX Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	55287L101
Earnings date	2026-11-09
Earnings time	bmo
Employees	63
Employees change	20
Employees growth	46.51%
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2024-09-13
Is primary listing	Yes
Is SPAC	No
ISIN number	US55287L1017
Last 10-K release date	2026-03-12
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$54.08
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	MBX
Tags	weight-loss
U.S. state	Indiana
Website	https://mbxbio.com

Metric

Value

Amount currency

USD

CIK code

0001776111

Company name

MBX Biosciences, Inc.

Country

United States

Country code

CUSIP number

55287L101

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

Employees growth

46.51%

Enterprise value

$2.2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2024-09-13

Is primary listing

Yes

Is SPAC

ISIN number

US55287L1017

Last 10-K release date

2026-03-12

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.6B

Market cap category

Mid-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$54.08

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

MBX

Tags

weight-loss

U.S. state

Indiana

Website

https://mbxbio.com

Metric	Value
Earnings yield	-4.45%
FCF / EV yield	-3.89%
FCF yield	-3.27%
P/B ratio	6.2x
Price / tangible book value	6.36x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-4.45%

FCF / EV yield

-3.89%

FCF yield

-3.27%

P/B ratio

6.2x

Price / tangible book value

6.36x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.7M
ROA	-22.08%
ROCE	-28.6%
ROE	-33.17%
ROIC	-23.29%

Metric

Value

Profit per employee

$-1.7M

ROA

-22.08%

ROCE

-28.6%

ROE

-33.17%

ROIC

-23.29%

Metric	Value
EPS growth years	2
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-2.5M
Depreciation and amortization	$253,000
EBIT	$-117.9M
EBITDA	$-117.7M
EPS	$-2.41
FCF per share	$-1.77
Financing cash flow	$278M
Free cash flow	$-85.2M
Free cash flow minus SBC	$-101.6M
Investing cash flow	$-180.8M
Net cash flow	$14.5M
Net income	$-104.3M
Operating cash flow minus SBC	$-99.1M
Operating income	$-117.9M
Stock-based compensation	$16.4M

Metric

Value

Capital expenditures

$-2.5M

Depreciation and amortization

$253,000

EBIT

$-117.9M

EBITDA

$-117.7M

EPS

$-2.41

FCF per share

$-1.77

Financing cash flow

$278M

Free cash flow

$-85.2M

Free cash flow minus SBC

$-101.6M

Investing cash flow

$-180.8M

Net cash flow

$14.5M

Net income

$-104.3M

Operating cash flow minus SBC

$-99.1M

Operating income

$-117.9M

Stock-based compensation

$16.4M

Metric	Value
Book value per share	$8.54
Debt / equity	0.01
Long-term assets	$8M
Long-term liabilities	$2.7M
Net cash (debt)	$415.2M
Net cash / market cap	15.94%
Net cash growth	85.16%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$7.4M
Shareholders' equity	$409.5M
Tangible book value	$409.5M
Tangible book value per share	$8.54
Total assets	$435.9M
Total cash	$418.6M
Total debt	$3.3M
Total liabilities	$26.4M
WACC	4.81%

Metric

Value

Book value per share

$8.54

Debt / equity

0.01

Long-term assets

$8M

Long-term liabilities

$2.7M

Net cash (debt)

$415.2M

Net cash / market cap

15.94%

Net cash growth

85.16%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$7.4M

Shareholders' equity

$409.5M

Tangible book value

$409.5M

Tangible book value per share

$8.54

Total assets

$435.9M

Total cash

$418.6M

Total debt

$3.3M

Total liabilities

$26.4M

WACC

4.81%

Metric	Value
Current assets	$427.9M
Current liabilities	$23.7M
Current ratio	18.08
Net working capital	$-13.7M
Quick ratio	17.82
Working capital	$404.2M

Metric

Value

Current assets

$427.9M

Current liabilities

$23.7M

Current ratio

18.08

Net working capital

$-13.7M

Quick ratio

17.82

Working capital

$404.2M

Metric	Value
Buyback yield / dilution	-62.14%
Dividend yield	0%
Shareholder yield	-62.14%

Metric

Value

Buyback yield / dilution

-62.14%

Dividend yield

Shareholder yield

-62.14%

Metric	Value
150-day SMA	$48.96
1D price change	2.1%
1M price change	0.84%
1M total return	0.84%
1W price change	0.28%
1W total return	0.28%
1Y price change	210.09%
1Y return CAGR	210.33%
1Y total return	210.09%
20-day SMA	$52.90
200-day SMA	$45.42
3M price change	-11.78%
3M total return	-11.78%
50-day SMA	$58.31
50-day SMA vs 200-day SMA	50over200
52-week high	$72.64
52-week high date	2026-08-05
52-week low	$16.95
52-week low date	2025-10-28
6M price change	69.16%
6M total return	69.16%
All-time high	$72.64
All-time high date	2026-08-05
All-time low	$4.81
All-time low date	2025-04-07
Average true range (ATR)	$3.39
Average volume	590.6K
Beta (1Y)	1.91
Beta (2Y)	1.95
Beta (5Y)	0.1
Change from 52-week high	-25.55%
Change from 52-week low	219.06%
Change from all-time high	-25.55%
Change from all-time low	1,025.03%
Change from open	1.65%
Day's gap	0.43%
Dollar volume	$12.2M
High price	$54.28
Low price	$52.77
Monthly RSI	65.82
Open price	$53.20
Position in 52-week range	86.75%
Premarket change	-2.59%
Premarket close	$52.97
Premarket price	$51.60
Previous close	$52.97
Price vs 150-day SMA	10.46%
Price vs 20-day SMA	2.24%
Price vs 200-day SMA	19.06%
Price vs 50-day SMA	-7.25%
Relative volume	0.38
Return from IPO open	135.23%
Return from IPO price	238.14%
RSI	49.8
Sharpe ratio	1.78
Sortino ratio	3.23
Volume	224.7K
Weekly RSI	53.3
YTD price change	71.47%
YTD total return	71.47%

Metric

Value

150-day SMA

$48.96

1D price change

2.1%

1M price change

0.84%

1M total return

0.84%

1W price change

0.28%

1W total return

0.28%

1Y price change

210.09%

1Y return CAGR

210.33%

1Y total return

210.09%

20-day SMA

$52.90

200-day SMA

$45.42

3M price change

-11.78%

3M total return

-11.78%

50-day SMA

$58.31

50-day SMA vs 200-day SMA

50over200

52-week high

$72.64

52-week high date

2026-08-05

52-week low

$16.95

52-week low date

2025-10-28

6M price change

69.16%

6M total return

69.16%

All-time high

$72.64

All-time high date

2026-08-05

All-time low

$4.81

All-time low date

2025-04-07

Average true range (ATR)

$3.39

Average volume

590.6K

Beta (1Y)

1.91

Beta (2Y)

1.95

Beta (5Y)

0.1

Change from 52-week high

-25.55%

Change from 52-week low

219.06%

Change from all-time high

-25.55%

Change from all-time low

1,025.03%

Change from open

1.65%

Day's gap

0.43%

Dollar volume

$12.2M

High price

$54.28

Low price

$52.77

Monthly RSI

65.82

Open price

$53.20

Position in 52-week range

86.75%

Premarket change

-2.59%

Premarket close

$52.97

Premarket price

$51.60

Previous close

$52.97

Price vs 150-day SMA

10.46%

Price vs 20-day SMA

2.24%

Price vs 200-day SMA

19.06%

Price vs 50-day SMA

-7.25%

Relative volume

0.38

Return from IPO open

135.23%

Return from IPO price

238.14%

RSI

49.8

Sharpe ratio

1.78

Sortino ratio

3.23

Volume

224.7K

Weekly RSI

53.3

YTD price change

71.47%

YTD total return

71.47%

Metric	Value
Float	31M
Float percentage	64.35%
Shares change (QoQ)	2.41%
Shares change (YoY)	62.14%
Shares held by insiders	2.74%
Shares held by institutions	83.02%
Shares outstanding	48.2M
Short % of float	14.41%
Short % of shares	9.27%
Short ratio	8.6 days

Metric

Value

Float

31M

Float percentage

64.35%

Shares change (QoQ)

2.41%

Shares change (YoY)

62.14%

Shares held by insiders

2.74%

Shares held by institutions

83.02%

Shares outstanding

48.2M

Short % of float

14.41%

Short % of shares

9.27%

Short ratio

8.6 days

MBX Biosciences, Inc. (MBX)

Price

Financial snapshot

Fair-value bridge

Latest news · MBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MBX

Frequently asked questions